Recent genetic profiling has shown that NSCLC has a preponderance of mutations affecting PTEN [20], the SETD1A/Wnt/β-catenin feedback loop [21], and the AKT-mTOR pathway [22]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.